The protein disulfide isomerases PDIA4 and PDIA6 mediate resistance to cisplatin-induced cell death in lung adenocarcinoma

Cell Death and Differentiation

Volumn 21, Issue 5, 2014, Pages 685-695

  Tufo, G ^a,b   Jones, A W E ^c   Wang, Z ^a,b   Hamelin, J ^d   Tajeddine, N ^e   Esposti, D D ^d   Martel, C ^a,b,f   Boursier, C ^g   Gallerne, C ^a,b   Migdal, C ^b,h   Lemaire, C ^a,i   Szabadkai, G ^c,j   Lemoine, A ^d   Kroemer, G ^e,k,l,m,n   Brenner, C ^a,b  

^a Universite Paris Sud   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d HÔPITAL PAUL BROUSSE   (France)

^e Institut Gustave Roussy   (France)

^f MONTREAL HEART INSTITUTE   (Canada)

^g IPSIT   (France)

^h Universite Paris Sud   (France)

ⁱ LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^j UNIVERSITY OF PADOVA   (Italy)

^k UNIVERSITÉ PARIS DESCARTES   (France)

^l INSTITUT GUSTAVE ROUSSY   (France)

^m CENTRE DE RECHERCHE DES CORDELIERS   (France)

ⁿ HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

more..

Author keywords

apoptosis; chemotherapy; necroptosis

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; BETA ACTIN; CALCIUM ION; CASPASE 3; CASPASE 4; CASPASE 7; CASPASE 9; CASPASE INHIBITOR; CISPLATIN; GLUCOSE REGULATED PROTEIN 78; HEAT SHOCK PROTEIN 70; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN DISULFIDE ISOMERASE; PROTEIN DISULFIDE ISOMERASE A4; PROTEIN DISULFIDE ISOMERASE A6; PROTEIN IRE1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; PDIA4 PROTEIN, HUMAN; PDIA6 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER RESISTANCE; CELL DEATH; CONTROLLED STUDY; CYTOSOL; DOWN REGULATION; ENDOPLASMIC RETICULUM; ENZYME INACTIVATION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; WESTERN BLOTTING; ADENOCARCINOMA; DRUG EFFECTS; DRUG RESISTANCE; ENZYMOLOGY; LUNG NEOPLASMS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; HUMANS; LUNG NEOPLASMS; PROTEIN DISULFIDE-ISOMERASES;

EID: 84898024593     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2013.193     Document Type: Article

References (48)

1. Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007; 87: 99-163. (Pubitemid 46209992)
2. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70. (Pubitemid 30046295)
3. Rebillard A, Tekpli X, Meurette O, Sergent O, LeMoigne-Muller G, Vernhet L et al. Cisplatin-induced apoptosis involves membrane fluidification via inhibition of NHE1 in human colon cancer cells. Cancer Res 2007; 67: 7865-7874. (Pubitemid 47281382)
4. Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O et al. Molecular mechanisms of cisplatin resistance. Oncogene 2012; 31: 1869-1883.
5. Köberle B, Tomicic M, Usanova S, Kaina B. Cisplatin resistance: preclinical findings and clinical implications. Biochim Biophys Acta 2010; 1806: 172-182.
6. Ma Y, Hendershot LM. The role of the unfolded protein response in tumour development: friend or foe? Nat Rev 2004; 4: 966-977. (Pubitemid 39626220)
7. Zhang K, Kaufman RJ. Signaling the unfolded protein response from the endoplasmic reticulum. J Biol Chem 2004; 279: 25935-25938. (Pubitemid 38798732)
8. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007; 8: 519-529. (Pubitemid 46985379)
9. Hersey P, Zhang XD. Adaptation to ER stress as a driver of malignancy and resistance to therapy in human melanoma. Pigment Cell Melanoma Res 2008; 21: 358-367. (Pubitemid 351678087)
10. Kim I, Xu W, Reed J. Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat Rev Drug Discov 2008; 7: 1013-1030.
11. Deniaud A, Sharaf el dein O, Maillier E, Poncet D, Kroemer G, Lemaire C et al. Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis. Oncogene 2008; 27: 285-299.
12. Lee AS. GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res 2007; 67: 3496-3499. (Pubitemid 46762126)
13. Han W, Xie J, Li L, Liu Z, Hu X. Necrostatin-1 reverts shikonin-induced necroptosis to apoptosis. Apoptosis 2009; 14: 674-686.
14. Kim Y, Haidl G, Schaefer M, Egner U, Herr J. Compartmentalization of a unique ADP/ATP carrier protein SFEC (Sperm Flagellar Energy Carrier, AAC4) with glycolytic enzymes in the fibrous sheath of the human sperm flagellar principal piece. Dev Biol 2007; 302: 463-476. (Pubitemid 46216265)
15. Rutkowski DT, Arnold SM, Miller CN, Wu J, Li J, Gunnison KM et al. Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins. PLoS Biol 2006; 4: e374.
16. Yao Z, Jones A, Fassone E, Sweeney M, Lebiedzinska M, Suski JM et al. PGC-1b mediates adaptive chemoresistance associated with mitochondrial DNA mutations. Oncogene 2013; 32: 2592-2600.
17. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012; 19: 107-120.
18. Tajeddine N, Galluzzi L, Kepp O, Hangen E, Morselli E, Senovilla L et al. Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death. Oncogene 2008; 27: 4221-4232. (Pubitemid 351969915)
19. Belfi CA, Chatterjee S, Gosky DM, Berger SJ, Berger NA. Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation. Biochem Biophys Res Commun 1999; 257: 361-368. (Pubitemid 29301450)
20. Konopleva M, Zhao S, Hu W, Jiang S, Snell V, Weidner D et al. The anti-apoptotic genes Bcl-X(L) and Bcl-2 are over-expressed and contribute to chemoresistance of non-proliferating leukaemic CD34 cells. Br J Haematol 2002; 118: 521-534. (Pubitemid 34994658)
21. Ravagnan L, Gurbuxani S, Susin SA, Maisse C, Daugas E, Zamzami N et al. Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat Cell Biol 2001; 3: 839-843. (Pubitemid 32842690)
22. Michels J, Vitale I, Senovilla L, Enot D, Garcia P, Lissa D et al. Synergistic interaction between cisplatin and PARP inhibitors in non-small cell lung cancer. Cell Cycle 2013; 12: 877-883.
23. Mandic A, Hansson J, Linder S, Shoshan MC. Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling. J Biol Chem 2003; 278: 9100-9106. (Pubitemid 36800390)
24. Chami M, Oulès B, Szabadkai G, Tacine R, Rizzuto R, Paterlini-Bréchot P. Role of SERCA1 truncated isoform in the proapoptotic calcium transfer from ER to mitochondria during ER stress. Mol Cell 2008; 32: 641-651.
25. Palmer AE, Jin C, Reed JC, Tsien RY. Bcl-2-mediated alterations in endoplasmic reticulum Ca2 analyzed with an improved genetically encoded fluorescent sensor. Proc Natl Acad Sci USA 2004; 101: 17404-17409. (Pubitemid 39657417)
26. Vicencio J, Ortiz C, Criollo A, Jones A, Kepp O, Galluzzi L et al. The inositol 1, 4, 5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1. Cell Death Differ 2009; 16: 1006-1017.
27. O transport ATPases. Arch Biochem Biophys 1992; 298: 313-317.
28. Schwaller M, Wilkinson B, Gilbert HF. Reduction-reoxidation cycles contribute to catalysis of disulfide isomerization by protein-disulfide isomerase. J Biol Chem 2003; 278: 7154-7159. (Pubitemid 36800714)
29. Roth RA. Bacitracin: an inhibitor of the insulin degrading activity of glutathione-insulin transhydrogenase. Biochem Biophys Res Commun 1981; 98: 431-438. (Pubitemid 11159482)
30. Lovat P, Corazzari M, Armstrong J, Martin S, Pagliarini V, Hill D et al. Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress. Cancer Res 2008; 68: 5363-5369.
31. Ellgaard L, Frickel EM. Calnexin, calreticulin, and ERp57: teammates in glycoprotein folding. Cell Biochem Biophys 2003; 39: 223-247. (Pubitemid 41270793)
32. Bian ZM, Elner SG, Elner VM. Dual involvement of caspase-4 in inflammatory and ER stress-induced apoptotic responses in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2009; 50: 6006-6014.
33. Hitomi J, Katayama T, Eguchi Y, Kudo T, Taniguchi M, Koyama Y et al. Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Abeta-induced cell death. J Cell Biol 2004; 165: 347-356. (Pubitemid 38649910)
34. Vandenabeele P, Declercq W, Van Herreweghe F, Vanden Berghe T. The role of the kinases RIP1 and RIP3 in TNF-induced necrosis. Sci Signal 2010; 3: re4.
35. Michels J, Vitale I, Galluzzi L, Adam J, Olaussen K, Kepp O et al. Cisplatin resistance associated with PARP hyperactivation. Cancer Res 2013; 73: 2271-2280.
36. Xu S, Butkevich A, Yamada R, Zhou Y, Debnath B, Duncan R et al. Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment. Proc Natl Acad Sci USA 2012; 109: 16348-16353.
37. Turano C, Coppari S, Altieri F, Ferraro A. Proteins of the PDI family: unpredicted non-ER locations and functions. J Cell Physiol 2002; 193: 154-163.
38. VanderWaal R, Spitz D, Griffith C, Higashikubo R, Roti Roti J. Evidence that protein disulfide isomerase (PDI) is involved in DNA-nuclear matrix anchoring. J Cell Biochem 2002; 85: 689-702. (Pubitemid 34462780)
39. Honjo Y, Ito H, Horibe T, Takahashi R, Kawakami K. Protein disulfide isomerase immunopositive glial cytoplasmic inclusions in patients with multiple system atrophy. Int J Neurosci 2011; 121: 543-550.
40. Honjo Y, Ito H, Horibe T, Takahashi R, Kawakami K. Protein disulfide isomerase-immunopositive inclusions in patients with Alzheimer disease. Brain Res 2010; 1349: 90-96.
41. Walker A, Farg M, Bye C, McLean C, Horne M, Atkin J. Protein disulphide isomerase protects against protein aggregation and is S-nitrosylated in amyotrophic lateral sclerosis. Brain Res 2010; 133: 105-116.
42. Uys J, Xiong Y, Townsend D. Nitrosative stress-induced S-glutathionylation of protein disulfide isomerase. Methods Enzymol 2011; 490: 321-332.
43. Bernardoni P, Fazi B, Costanzi A, Nardacci R, Montagna C, Filomeni G et al. Reticulon1-C modulates protein disulphide isomerase function. Cell Death Dis 2013; 4: e581.
44. Nakamura T, Lipton S. Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases. Cell Death Differ 2011; 18: 1478-1486.
45. Krynetskaia N, Phadke M, Adhav S, Krynetskiy E. Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage. Mol Cancer Ther 2009; 4: 864-872.
46. Martel C, Allouche M, Esposti DD, Fanelli E, Boursier C, Henry C et al. GSK3-mediated VDAC phosphorylation controls outer mitochondrial membrane permeability during lipid accumulation. Hepatology 2013; 57: 93-102.
47. Le Bras M, Borgne-Sanchez A, Touat Z, Sharaf el dein O, Deniaud A, Maillier E et al. Chemosensitization by knock-down of adenine nucleotide translocase-2. Cancer Res 2006; 66: 9143-9152. (Pubitemid 44521134)
48. Gu Y, Di W, Kelsell D, Zicha D. Quantitative fluorescence resonance energy transfer (FRET) measurement with acceptor photobleaching and spectral unmixing. J Microsc 2004; 215: 162-173. (Pubitemid 39118333)